Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 28S ribosomal RNA sarcin-ricin loop (SRL) is a highly conserved 12-nucleotide sequence in the large ribosomal subunit that is critical for protein synthesis (Endo & Tsurugi, 1987). It serves as the primary binding site for translational GTPases, such as elongation factors eEF-1 and eEF-2, which facilitate the movement of mRNA and tRNA through the ribosome (Shi et al., 2012). The SRL is the specific molecular target for Ribosome-Inactivating Proteins (RIPs), most notably the ricin A-chain (RTA) and Shiga toxins (Stx). These toxins function as RNA N-glycosidases that specifically depurinate the adenine residue at position A4324 in humans (Grela et al., 2019). This single modification prevents the binding of elongation factors, leading to a complete arrest of protein translation and subsequent cell death via apoptosis (Stirpe, 2004). Because of its essentiality and the extreme potency of the toxins that target it, the SRL is a major focus in toxicology and biodefense research. Additionally, the SRL-targeting mechanism is exploited in the development of immunotoxins, where RIPs are conjugated to antibodies for targeted cancer therapy (Walsh et al., 2013).
N-glycosidase-mediated depurination of adenine A4324, which prevents the binding of elongation factors to the ribosome.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 28S ribosomal RNA sarcin-ricin loop (SRL).